Richard R. Furman
Impact in
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 205
- Chronic Lymphocytic Leukemia Research 202
-
- Lymphoma Diagnosis and Treatment 159
- Co-authors
- John P. Leonard (101 shared papers)Morton Coleman (70 shared papers)Steven Coutré (65 shared papers)John C. Byrd (65 shared papers)Ian W. Flinn (53 shared papers)Jeff P. Sharman (42 shared papers)William G. Wierda (42 shared papers)Peter Martin (51 shared papers)
- Journals
- Blood (130 papers)Journal of Clinical Oncology (56 papers)Blood Advances (7 papers)Clinical Cancer Research (7 papers)Haematologica (5 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Richard R. Furman
293 papers receiving 12.1k citations
Richard R. Furman's Hit Papers
Peers
Comparison fields: 5 of 97
- Genetics 7.2k
- Pathology and Forensic Medicine 6.8k
- Hematology 2.2k
- Immunology 3.2k
- Oncology 3.2k
Countries citing papers authored by Richard R. Furman
This map shows the geographic impact of Richard R. Furman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard R. Furman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard R. Furman more than expected).
Fields of papers citing papers by Richard R. Furman
This network shows the impact of papers produced by Richard R. Furman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard R. Furman. The network helps show where Richard R. Furman may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard R. Furman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 304 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies Hit paper breakdown → | 2012 | 879 |
| 2 | Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib Hit paper breakdown → | 2015 | 494 |
| 3 | Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia Hit paper breakdown → | 2014 | 479 |
| 4 | Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study Hit paper breakdown → | 2011 | 454 |
| 5 | 2010 | 434 | |
| 6 | 2015 | 308 | |
| 7 | 2017 | 268 | |
| 8 | 2018 | 261 | |
| 9 | 2010 | 247 | |
| 10 | 2009 | 244 | |
| 11 | 2015 | 234 | |
| 12 | 2000 | 226 | |
| 13 | 2003 | 206 | |
| 14 | 2014 | 205 | |
| 15 | 2004 | 194 | |
| 16 | 2010 | 190 | |
| 17 | 2013 | 175 | |
| 18 | 2014 | 170 | |
| 19 | 2015 | 167 | |
| 20 | 2009 | 163 |
About Richard R. Furman
Richard R. Furman is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Oncology and Hematology, having authored 304 papers that have together received 12.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (202 papers), Lymphoma Diagnosis and Treatment (159 papers), Immunodeficiency and Autoimmune Disorders (43 papers), Monoclonal and Polyclonal Antibodies Research (40 papers), Chronic Myeloid Leukemia Treatments (29 papers), Advanced Breast Cancer Therapies (27 papers), CAR-T cell therapy research (26 papers) and Acute Lymphoblastic Leukemia research (24 papers). The work is most often cited by research in Genetics (7.2k citations), Pathology and Forensic Medicine (6.8k citations), Hematology (2.2k citations), Immunology (3.2k citations) and Oncology (3.2k citations). Richard R. Furman has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include John P. Leonard, Morton Coleman, Steven Coutré, John C. Byrd, Ian W. Flinn, Jeff P. Sharman, William G. Wierda, Peter Martin, Jennifer R. Brown and Jia Ruan. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Clinical Cancer Research and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.